Search by Drug Name or NDC

    NDC 68093-7319-01 MG217CoolingBurnSpray .013; .04 g/g; g/g Details

    MG217CoolingBurnSpray .013; .04 g/g; g/g

    MG217CoolingBurnSpray is a TOPICAL SPRAY in the HUMAN OTC DRUG category. It is labeled and distributed by Wisconsin Pharmacal Company. The primary component is BENZALKONIUM CHLORIDE; LIDOCAINE.

    Product Information

    NDC 68093-7319
    Product ID 68093-7319_d57c1968-21f4-0c99-e053-2a95a90a37b6
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name MG217CoolingBurnSpray
    Proprietary Name Suffix n/a
    Non-Proprietary Name LIDOCAINE, BENZALKONIUM CHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form SPRAY
    Route TOPICAL
    Active Ingredient Strength .013; .04
    Active Ingredient Units g/g; g/g
    Substance Name BENZALKONIUM CHLORIDE; LIDOCAINE
    Labeler Name Wisconsin Pharmacal Company
    Pharmaceutical Class Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part348
    Listing Certified Through 2023-12-31

    Package

    NDC 68093-7319-01 (68093731901)

    NDC Package Code 68093-7319-1
    Billing NDC 68093731901
    Package 113 g in 1 CAN (68093-7319-1)
    Marketing Start Date 2020-04-17
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL a3501096-14db-4d1f-e053-2995a90a8947 Details

    Revised: 1/2022